EQUAL aims to study how the level of renal function, and uraemic signs and symptoms can be used to determine when dialysis should be initiated in elderly patients.
The EQUAL study is part of the ERA-EDTA registry. In the setting of an increasing number of National Registries in Europe, the aim of the ERA-EDTA Registry (the Registry) is to complement and build on the analyses which the National Registries themselves can carry out. In particular, the Registry will compare disease patterns and their treatment in the various member countries, study treatment outcomes, carry out analyses where patient numbers in individual National Registries are small and build up a demographic picture of renal failure within the member countries.
The Registry will gather data by establishing links with National and/or large Regional Registries in the countries within or bordering Europe or bordering the Mediterranean Sea. By means of these links, transfer of data can take place to the Registry and transfer of the information arising from completed analyses can also be communicated back to the National Registries.
You can find more information on the EQUAL study website.
APH contact person: Nick Chesnaye
Conact: erareg@amsterdamumc.nl